Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 210

The DOI matches its Crossref record.

Natural history of murine γ-herpesvirus infection

Open access
Nash, Anthony A., Dutia, Bernadette M., Stewart, James P., Davison, Andrew J. · 2001 · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences

Abstract

Murine γ–herpesvirus 68 (MHV–68) is a natural pathogen of small rodents and insectivores (mice, voles and shrews). The primary infection is characterized by virus replication in lung epithelial cells and the establishment of a latent infection in B lymphocytes. The virus is also observed to persist in lung epithelial cells, dendritic cells and macrophages. Splenomegaly is observed two weeks after infection, in which there is a CD4 + T–cell–mediated expansion of B and T cells in the spleen. At three weeks post–infection an infectious mononucleosis–like syndrome is observed involving a major expansion of Vβ4 + CD8 + T cells. Later in the course of persistent infection, ca . 10% of mice develop lymphoproliferative disease characterized as lymphomas of B–cell origin. The genome from MHV–68 strain g2.4 has been sequenced and contains ca . 73 genes, the majority of which are collinear and homologous to other γ–herpesviruses. The genome includes cellular homologues for a complement–regulatory protein, Bcl–2, cyclin D and interleukin–8 receptor and a set of novel genes M1 to M4. The function of these genes in the context of latent infections, evasion of immune responses and virus–mediated pathologies is discussed. Both innate and adaptive immune responses play an active role in limiting virus infection. The absence of type I interferon (IFN) results in a lethal MHV–68 infection, emphasizing the central role of these cytokines at the initial stages of infection. In contrast, type II IFN is not essential for the recovery from infection in the lung, but a failure of type II IFN receptor signalling results in the atrophy of lymphoid tissue associated with virus persistence. Splenic atrophy appears to be the result of immunopathology, since in the absence of CD8 + T cells no pathology occurs. CD8 + T cells play a major role in recovery from the primary infection, and also in regulating latently infected cells expressing the M2 gene product. CD4 + T cells have a key role in surveillance against virus recurrences in the lung, in part mediated through ‘help’ in the genesis of neutralizing antibodies. In the absence of CD4 + T cells, virus–specific CD8 + T cells are able to control the primary infection in the respiratory tract, yet surprisingly the memory CD8 + T cells generated are unable to inhibit virus recurrences in the lung. This could be explained in part by the observations that this virus can downregulate major histocompatibility complex class I expression and also restrict inflammatory cell responses by producing a chemokine–binding protein (M3 gene product). MHV–68 provides an excellent model to explore methods for controlling γ–herpesvirus infection through vaccination and chemotherapy. Vaccination with gp150 (a homologue of gp350 of Epstein–Barr virus) results in a reduction in splenomegaly and virus latency but does not block replication in the lung, nor the establishment of a latent infection. Even when lung virus infection is greatly reduced following the action of CD8 + T cells, induced via a prime–boost vaccination strategy, a latent infection is established. Potent antiviral compounds such as the nucleoside analogue 2′deoxy–5–ethyl–beta–4′–thiouridine, which disrupts virus replication in vivo , cannot inhibit the establishment of a latent infection. Clearly, devising strategies to interrupt the establishment of latent virus infections may well prove impossible with existing methods.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1098/rstb.2000.0779

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Nash, A. A., Dutia, B. M., Stewart, J. P., & Davison, A. J.
Venue
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences
Published
2001-04-29
Volume
356
Issue
1408
Pages
569-579
ISSN
  • 0962-8436 (ISSN-L)
  • 1471-2970
OpenAlex
W2170879194
Cited by
210
References
0
FWCI
5.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.